IP-10 and MCP-1 as biomarkers associated with disease severity of COVID-19
Abstract Background COVID-19 is a viral respiratory disease caused by the severe acute respiratory syndrome-Coronavirus type 2 (SARS-CoV-2). Patients with this disease may be more prone to venous or arterial thrombosis because of the activation of many factors involved in it, including inflammation,...
Saved in:
Main Authors: | Yu Chen (Author), Jinglan Wang (Author), Chenxi Liu (Author), Longxiang Su (Author), Dong Zhang (Author), Junping Fan (Author), Yanli Yang (Author), Meng Xiao (Author), Jing Xie (Author), Yingchun Xu (Author), Yongzhe Li (Author), Shuyang Zhang (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2020-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
IP-10 and MCP-1 gene polymorphisms in Chinese patients with chronic immune thrombocytopenia
by: Xian Zhang, et al.
Published: (2019) -
MIP-1α and MCP-1 as salivary biomarkers in periodontal disease
by: K.J. Nisha, et al.
Published: (2018) -
Syndecan-1, an indicator of endothelial glycocalyx degradation, predicts outcome of patients admitted to an ICU with COVID-19
by: Dong Zhang, et al.
Published: (2021) -
Plasma CXCL8 and MCP-1 as surrogate plasma biomarkers of latent tuberculosis infection among household contacts-A cross-sectional study.
by: Sivaprakasam T Selvavinayagam, et al.
Published: (2023) -
Plasma CXCL8 and MCP-1 as surrogate plasma biomarkers of latent tuberculosis infection among household contacts-A cross-sectional study
by: Sivaprakasam T. Selvavinayagam, et al.
Published: (2023)